N/A
N=84
Concussion Testing: A Novel Non-invasive Concussion Detection Device
Concussion
Bottom Line
View on ClinicalTrials.gov: NCT02370914 ↗Enrolled (actual)
84
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcome: Primary: A Measure Assessing the Sensitivity and Specificity Rate Based on the Nautilus Neurowave Data — 77; 87 percentage of participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Nautilus NeuroWaveTM System (Device); SCAT (Behavioral)
- Age
- Pediatric, Adult · 14+ yrs
- Sex
- Male
- Sponsor
- Jan Medical, Inc.
- Primary completion
- Dec 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY A Measure Assessing the Sensitivity and Specificity Rate Based on the Nautilus Neurowave Data |
77; 87 | — |
Summary
The purpose of this study is to establish and evaluate a distinctive signal for concussion.
Eligibility Criteria
Inclusion Criteria
- Junior Varsity and Varsity Players a local High School.
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT02370914). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.